New RSV shot tested in seniors to fight winter virus
NCT ID NCT07208461
Summary
This study is testing a new vaccine called LYB005 to prevent serious illness from Respiratory Syncytial Virus (RSV) in adults aged 60 and older. Researchers will give 700 participants either one of six different vaccine formulas or a placebo shot to compare how well their immune systems respond and to check for side effects. The main goal is to see if the vaccine safely triggers strong antibody production against RSV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Disease Control and Prevention of Dangyang City
Dangyang, China
Conditions
Explore the condition pages connected to this study.